跳至主要内容
临床试验/NCT01868633
NCT01868633已完成4 期

The Effect of a Single Intraoperative Dose of Dexamethasone in Combination With Intrathecal Morphine for Post Cesarean Delivery Analgesia

University of Iowa1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2013年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
52
试验地点
1
主要终点
Postoperative Analgesia

研究概览

简要总结

The purpose of this study is to assess the effectiveness intravenous (IV) dexamethasone when used as part of a multimodal regimen to manage post cesarean delivery pain.

We hypothesize that a single dose of IV dexamethasone administered, as part of a multimodal analgesia after spinal anesthesia will significantly reduce post cesarean delivery opioid consumption and pain

详细描述

After the subjects consent to participate in the study they will be transferred to the operating room for their scheduled cesarean delivery. They will have their routine spinal anesthesia with the dosages of drugs used standardized, and a standardized regimen to manage hypotension. After delivery of the baby the subjects will be administered either the study drug or placebo depending on the randomization. The subjects will then be prescribed a standard post-operative analgesia regimen. The subjects will then be interviewed at 12,24 and 48 hours post cesarean delivery. During the interview the subjects will be asked to rate their pain, nausea and vomiting and pruritus. They will also be asked to rate their quality of recovery from the surgery using Quality of Recovery-40 questionnaire. The subjects will be contacted 6 months after the study to rate their pain using a Short-Form McGill Pain Questionnaire

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • English Speaking
  • Non-laboring women
  • Scheduled Elective Cesarean section under spinal anesthesia
  • American Society of Anesthesiologists I-II physical status

排除标准

  • Contraindications to spinal anesthesia
  • allergy to study medication
  • patients with allergy to morphine
  • patients with uncontrolled hypertension
  • history of peptic ulcer disease
  • liver cirrhosis
  • diabetes mellitus
  • known IV drug abusers
  • patients with chronic pain or on long term opioids
  • patients administered steroids in the past week
  • women with fetuses having known congenital abnormalities
  • psychiatric illness such that they are unable to comprehend or participate in study questions
  • patients on antiviral medications or live virus vaccines would also be excluded.

研究组 & 干预措施

Dexamethasone & spinal morphine

Active Comparator

intrathecal morphine administered at time of spinal anesthesia. After cesarean delivery 8mg (2ml) of Dexamethasone given intraoperatively

干预措施: Dexamethasone (Drug)

Placebo injection and spinal morphine

Placebo Comparator

intrathecal morphine administered at time of spinal anesthesia. After cesarean delivery 2ml of placebo (Normal saline) drawn to mimic active drug given intraoperatively

干预措施: Placebo (Drug)

结局指标

主要结局

Postoperative Analgesia

时间窗: 24 hours

Comparison of postoperative opioid analgesia use between the 2 groups

次要结局

  • Postoperative Pain at Rest and With Movement 24 Hours After Cesarean Delivery(24 hours)
  • Quality of Recovery(48 hours)
  • Incidence and Severity of Nausea and Pruritus(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Unyime Ituk

Assistant Professor

University of Iowa

研究点 (1)

Loading locations...

相似试验

Dexamethasone for Post Cesarean Delivery Analgesia | 临床试验